Metabolic profiling of praziquantel-mediated prevention of opisthorchis viverrini-induced cholangiocyte transformation in the hamster model of cholangiocarcinoma

5Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

Background: Opisthorchis viverrini (Ov) infectioninduced cholangiocarcinoma (CCA) is a major public health problem in northeastern Thailand. Praziquantel was shown to prevent CCA development in an Ov-infected hamster model; however, the molecular mechanism remains unknown. Materials and Methods: In this study, we used a hamster model with Ov and N-nitrosodimethylamine-induced CCA to study the mechanisms of praziquantel action. The liver tissues from the hamsters with and without praziquantel treatment were analyzed using 1H nuclear magnetic resonance spectroscopy. Results: A total of 14 metabolites were found to be significantly different between the two groups. Furthermore, the combination of acetate, inosine and sarcosine was shown to exert an anti-inflammatory effect through interleukin-6 inhibition in a macrophage cell line, suggesting a mechanism by which praziquantel may prevent inflammation caused by Ov, cholangiocyte transformation and further CCA develpoment. Conclusion: These findings might avail the development of a preventive strategy for CCA in high-risk populations.

Cite

CITATION STYLE

APA

Prommajun, P., Phetcharaburanin, J., Namwat, N., Klanrit, P., Sa-Ngiamwibool, P., Thanee, M., … Loilome, W. (2021). Metabolic profiling of praziquantel-mediated prevention of opisthorchis viverrini-induced cholangiocyte transformation in the hamster model of cholangiocarcinoma. Cancer Genomics and Proteomics, 18(1), 29–42. https://doi.org/10.21873/CGP.20239

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free